Diagnostics to enable malaria and neglected tropical diseases
Ended Definitive Contract Awarded
- Contract number
- 75N93018C00020
- Awardee
-
Crosslife Technologies Inc. UEI LFE6DJ6KL4E5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $216,444
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Pre-Solicitation · PHS20181 · Posted Jun 29, 2017
- Contract value 100% obligated
- $216,444.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 16 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98102, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS 2018-1, which sought proposals from small businesses to address a range of research topics relevant to the National Institutes of Health and Centers for Disease Control and Prevention. The contract is a firm fixed price definitive contract with a period of performance ending on July 31, 2019.
Quick answers
Who was awarded contract 75N93018C00020?
75N93018C00020 was awarded to Crosslife Technologies Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 31, 2018.
How much is contract 75N93018C00020 worth?
The government has obligated $216,444 on 75N93018C00020.
Was contract 75N93018C00020 competed?
The extent of competition for 75N93018C00020 was full and open competition after exclusion of sources. The government received 16 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award